Dazhuo Shi

1.4k citations
81 papers · 1.0k indexed · h-index 19

Dazhuo Shi

76 papers receiving 995 citations

Peers

Dazhuo Shi
Comparison fields: 5 of 114
  • Complementary and alternative medicine 274
  • Pharmacology 133
  • Cardiology and Cardiovascular Medicine 266
  • Cancer Research 117
  • Molecular Biology 431
Replace Mingjing Zhao with:
Mingjing Zhao China
Xiaoyi Bao China
Hai‐Han Liao China
Xiaohu Chen China
Ming Guo China
Gaojun Wu China
Peiren Shan China
Chuan‐She Wang China
Meili Lü China
Huifeng Hao China
Dazhuo Shi relative to Mingjing Zhao China Mingjing Zhao's profile →
Citations per field
00.5×1.5×2.3×
Mingjing Zhao · 1×
Citations per year

Countries citing papers authored by Dazhuo Shi

Since Specialization
Citations

This map shows the geographic impact of Dazhuo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dazhuo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dazhuo Shi more than expected).

Fields of papers citing papers by Dazhuo Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dazhuo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dazhuo Shi. The network helps show where Dazhuo Shi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dazhuo Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dazhuo Shi Line = papers co-authored together Dazhuo Shi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20241
3 20249
4 20243
5 202421
6 20235
7 20238
8 20233
9 20233
10 20223
11 202137
12 202041
13 201610
14 201635
15 20168
16 20136
17 201151
18 201142
19 200911
20
Effects of Qixue Bingzhi Prescription on Hypersensitive C-reactive Protein and Other Indexes in the Patient of Cervical Atherosclerosis
19921

About Dazhuo Shi

Dazhuo Shi is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 81 papers that have together received 1.0k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Lipid metabolism and disorders (8 papers), Coronary Interventions and Diagnostics (8 papers), MicroRNA in disease regulation (7 papers), Traditional Chinese Medicine Studies (7 papers), Ginseng Biological Effects and Applications (6 papers) and Pharmacological Effects of Natural Compounds (6 papers). The work is most often cited by research in Complementary and alternative medicine (274 citations), Pharmacology (133 citations) and Cardiology and Cardiovascular Medicine (266 citations). Dazhuo Shi has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Ming Guo, Yue Liu, Keji Chen, Zhu-ye Gao, Hui-jun Yin, Hua Qu, Hao Xu, Chen Wang, Xiuhua Liu and Xiaojuan Ma. Their work appears in journals such as Scientific Reports, Journal of Ethnopharmacology and European Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026